Laurence Moerlooze - Bavarian Nordic Ex Officer
| BVNRY Stock | USD 8.96 0.12 1.36% |
Insider
Laurence Moerlooze is Ex Officer of Bavarian Nordic AS
| Age | 59 |
| Phone | 45 33 26 83 83 |
| Web | https://www.bavarian-nordic.com |
Bavarian Nordic Management Efficiency
The company has return on total asset (ROA) of (0.0197) % which means that it has lost $0.0197 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0942) %, meaning that it generated substantial loss on money invested by shareholders. Bavarian Nordic's management efficiency ratios could be used to measure how well Bavarian Nordic manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Behrad Derakhshan | Edgewise Therapeutics | 44 | |
| Ryan Baker | Iteos Therapeutics | N/A | |
| Christina BBA | Antibe Therapeutics | N/A | |
| Andreas EMBA | Molecular Partners AG | 58 | |
| Thomas Schwerzmann | Molecular Partners AG | N/A | |
| James Goding | Opthea | N/A | |
| Seth Lewis | Molecular Partners AG | N/A | |
| , MBA | Molecular Partners AG | 51 | |
| Alexander Zurcher | Molecular Partners AG | 49 | |
| Philip Stern | Antibe Therapeutics | N/A | |
| MEng CFA | Antibe Therapeutics | N/A | |
| Michael Gerometta | Opthea | 59 | |
| Ana Stegic | Antibe Therapeutics | N/A | |
| Alan Russell | Edgewise Therapeutics | 54 | |
| MBA MSc | Antibe Therapeutics | 65 | |
| MBA DO | Antibe Therapeutics | 57 | |
| Michael Pitzner | Molecular Partners AG | N/A | |
| Ian Leitch | Opthea | 61 | |
| Yvonne McGrath | Iteos Therapeutics | 50 | |
| MBA MBA | Antibe Therapeutics | N/A | |
| Michael Carruthers | Edgewise Therapeutics | 66 | |
Management Performance
| Return On Equity | -0.0942 | |||
| Return On Asset | -0.0197 |
Bavarian Nordic AS Leadership Team
Elected by the shareholders, the Bavarian Nordic's board of directors comprises two types of representatives: Bavarian Nordic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bavarian. The board's role is to monitor Bavarian Nordic's management team and ensure that shareholders' interests are well served. Bavarian Nordic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bavarian Nordic's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anu Kerns, Ex Officer | ||
| Russell Thirsk, Ex COO | ||
| Laurence Moerlooze, Ex Officer | ||
| Paul MSc, CEO Pres | ||
| JeanChristophe May, Ex Officer | ||
| Rolf Srensen, VP Communications | ||
| Henrik MSc, CFO VP |
Bavarian Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Bavarian Nordic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0942 | |||
| Return On Asset | -0.0197 | |||
| Profit Margin | (0.25) % | |||
| Operating Margin | (0.15) % | |||
| Current Valuation | 1.95 B | |||
| Shares Outstanding | 211.77 M | |||
| Price To Earning | 39.62 X | |||
| Price To Book | 2.20 X | |||
| Price To Sales | 0.93 X | |||
| Revenue | 1.9 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bavarian Pink Sheet Analysis
When running Bavarian Nordic's price analysis, check to measure Bavarian Nordic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bavarian Nordic is operating at the current time. Most of Bavarian Nordic's value examination focuses on studying past and present price action to predict the probability of Bavarian Nordic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bavarian Nordic's price. Additionally, you may evaluate how the addition of Bavarian Nordic to your portfolios can decrease your overall portfolio volatility.